Left atrial appendage occlusion in patients with cirrhotic liver disease: the importance of patient selection-Reference-Cited by-同舟云学术

Left atrial appendage occlusion in patients with cirrhotic liver disease: the importance of patient selection

Published:2023-03-01 Issue:4 Volume:25 Page:1315-1317
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Calvert Peter¹^ORCID,Gupta Dhiraj¹^ORCID

Affiliation:

1. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital , Thomas Drive, Liverpool L14 3PE , UK

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/europace/article-pdf/25/4/1315/49919807/euad032.pdf

Reference14 articles.

1. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: a systematic review and meta-analysis;Zhu;Pacing Clin Electrophysiol,2022

2. Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation; a United States National Cohort Study;Mir;Europace,2022

3. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension;Vandenberk;Aliment Pharmacol Ther,2023

4. Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation;Serper;Hepatology,2021

5. Retrospective review on the safety and efficacy of direct oral anticoagulants compared with warfarin in patients with cirrhosis;Jones;Fed Pract,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper;Europace;2024-01-31